DOCSLIB.ORG

Vireo Health International, Inc. Form 10-12G/A Filed 2020-12-22

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vireo Health International, Inc. Form 10-12G/A Filed 2020-12-22 SECURITIES AND EXCHANGE COMMISSION FORM 10-12G/A Initial general form for registration of a class of securities pursuant to Section 12(g) [amend] Filing Date: 2020-12-22 SEC Accession No. 0001104659-20-138170 (HTML Version on secdatabase.com) FILER Vireo Health International, Inc. Mailing Address Business Address 207 SOUTH 9TH STREET 207 SOUTH 9TH STREET CIK:1771706| IRS No.: 000000000 | State of Incorp.:A1 | Fiscal Year End: 1231 MINNEAPOLIS MN 55402 MINNEAPOLIS MN 55402 Type: 10-12G/A | Act: 34 | File No.: 000-56225 | Film No.: 201405579 604-617-5421 SIC: 2834 Pharmaceutical preparations Copyright © 2020 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 to FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 VIREO HEALTH INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) British Columbia 82-3835655 (State or other jurisdiction of (I.R.S. employer incorporation or organization) identification no.) 207 South 9th Street Minneapolis, Minnesota 55402 (Address of principal executive offices and zip code) (612) 999-1606 (Registrant’s telephone number, including area code) Securities to be registered pursuant to Section 12(b) of the Act: None Securities to be registered pursuant to Section 12(g) of the Act: Subordinate Voting Shares Multiple Voting Shares Super Voting Shares (Title of class) Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer x Smaller reporting company x Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financing accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ TABLE OF CONTENTS Page IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY 1 Copyright © 2020 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS 2 RISK FACTORS SUMMARY 2 ITEM 1. BUSINESS 6 ITEM 1A. RISK FACTORS 30 ITEM 2. FINANCIAL INFORMATION 62 ITEM 3. PROPERTIES 86 ITEM 4. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 86 ITEM 5. DIRECTORS AND EXECUTIVE OFFICERS 86 ITEM 6. EXECUTIVE COMPENSATION 93 ITEM 7. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE 97 ITEM 8. LEGAL PROCEEDINGS 98 ITEM 9. MARKET PRICE OF AND DIVIDENDS ON THE REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 99 ITEM 10. RECENT SALES OF UNREGISTERED SECURITIES 101 ITEM 11. DESCRIPTION OF THE REGISTRANT’S SECURITIES TO BE REGISTERED 101 ITEM 12. INDEMNIFICATION OF DIRECTORS AND OFFICERS 110 ITEM 13. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 112 ITEM 14. CHANGES IN AND DISAGREEMENTS WITH AUDITORS ON ACCOUNTING AND FINANCIAL DISCLOSURE 113 ITEM 15. FINANCIAL STATEMENTS AND EXHIBITS 113 APPENDIX A 115 EXHIBIT INDEX 119 Implications of Being an Emerging Growth Company As a company with less than $1.07 billion in revenue during our most recently completed fiscal year, we qualify as an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, which we refer to as the “Securities Act,” as modified by the Jumpstart Our Business Startups Act of 2012, or the “JOBS Act.” As an emerging growth company, we may take advantage of specified reduced disclosure and other exemptions from requirements that are otherwise applicable to public companies that are not emerging growth companies. These provisions include: · Reduced disclosure about our executive compensation arrangements; · Exemptions from non-binding shareholder advisory votes on executive compensation or golden parachute arrangements; · Our election under Section 107(b) of the JOBS Act to delay adoption of new or revised accounting standards with different effective dates for public and private companies until those standards would otherwise apply to private companies; and · Exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting. We may take advantage of these exemptions for up to five years or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more than $1.07 billion in annual revenues as of the end of a fiscal year, if we are deemed to be a large-accelerated filer under the rules of the Securities and Exchange Commission (the “SEC”) or if we issue more than $1.0 billion of non-convertible debt over a three-year period. You should rely only on the information contained in this document or to which we have referred you. We have not authorized anyone to provide you with information that is different. You should assume that the information contained in this document is accurate as of the date of this registration statement on Form 10 only. This registration statement will become effective automatically 60 days from the date of the original filing (the “Effective Date”), pursuant to Section 12(g)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As of the Effective Date, we will become subject to the reporting requirements of Section 13(a) Copyright © 2020 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document under the Exchange Act and will be required to file annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and we will be required to comply with all other obligations of the Exchange Act applicable to issuers filing registration statements pursuant to Section 12(g) of the Exchange Act. Use of Names In this Amendment No. 1 to Vireo Health International, Inc.’s registration statement on Form 10, unless the context otherwise requires, the terms “we,” “us,” “our,” “Company” or “Vireo” refer to Vireo Health International, Inc. together with its wholly-owned subsidiaries. References to “Darien Business Development Corp” or “Darien” refer to the Company prior to completion of the Transaction (as hereinafter defined). Currency Unless otherwise indicated, all references to “$” or “US$” in this registration statement refer to United States dollars, and all references to “C$” refer to Canadian dollars. 1 Disclosure Regarding Forward-Looking Statements This Amendment No. 1 to the registration statement on Form 10 contains statements that we believe are, or may be considered to be, “forward-looking statements.” Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on current beliefs, expectations or assumptions regarding the future of the business, future plans and strategies, operational results and other future conditions of the Company. All statements other than statements of historical fact included in this registration statement regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “plans,” “expects” or “does not expect,” “is expected,” “look forward to,” “budget,” “scheduled,” “estimates,” “forecasts,” “will continue,” “intends,” “the intent of,” “have the potential,” “anticipates,” “does not anticipate,” “believes,” “should,” “should not,” or variations of such words and phrases that indicate that certain actions, events or results “may,” “could,” “would,” “might,” or “will,” “be taken,” “occur,” or “be achieved,” or the negative of these terms or variations of them or similar terms. Furthermore, forward-looking statements may be included in various filings that we make with the SEC or press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that predictions, forecasts, projections and other forward-looking statements will not be achieved. We caution readers not to place undue reliance on these statements as a number of important factors could cause the actual results to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates and intentions expressed in such forward-looking statements. Risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and statements
Load more

Recommended publications
  • BLOSSOM ENTERPRISES, LLC Application ID 352
    Ohio Medical Marijuana Dispensary Application BLOSSOM ENTERPRISES, LLC Application ID 352 Demographic Information(Business Contact) A-1.1 Business Name, as it appears on the Applicant’s certificate of incorporation, charter, bylaws, partnership agreement or other legal business formation documents Blossom Enterprises, LLC A-1.2 Other trade names and DBA (doing business as) names Blossom A-1.3 Business Street Address 508 Old Harbor Court A-1.4 City Centerville A-1.5 State OH A-1.6 Zip Code 45458 A-1.7 Phone 2027704708 A-1.8 Email [email protected] Demographic Information(Primary Contact/Registered Agent) A-2.1 Please select: Primary Contact, or Registered Agent for this Application PRIMARY CONTACT A-2.2 First Name Jumoke A-2.3 Middle Name No response provided by applicant A-2.4 Last Name Akinnagbe A-2.5 Street Address 508 Old Harbor Court A-2.6 City Centerville A-2.7 State OH A-2.8 Zip Code 45458 A-2.9 Phone 2027704708 A-2.10 Email [email protected] Demographic Information(Applicant Organization and Tax Status) A-3.1 Select One Limited Liability Company A-3.1A If other, explain No response provided by applicant A-3.2 State of Incorporation or Registration DE A-3.3 Date of Formation 11/03/2017 A-3.4 Business Name on Formation Documents Blossom Enterprises LLC A-3.5 Federal Employer ID number This response has been entirely redacted A-3.6 Ohio Unemployment Compensation Account Number No response provided by applicant A-3.7 Ohio Department of Taxation Number (if Applicant is currently doing business in Ohio) No response provided by applicant A-3.8 Ohio Workers’ Compensation Policy Number (if Applicant is currently doing business in Ohio) No response provided by applicant A-3.9 The Applicant attests that workers’ compensation insurance will be obtained by the time the State of Ohio Board of Pharmacy determines the Applicant to be operational under the Act and regulations.
    [Show full text]
  • Harvest Enterprises Group of Companies
    HARVEST ENTERPRISES GROUP OF COMPANIES INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017 (Unaudited) (Expressed in United States Dollars) (0) HARVEST ENTERPRISES GROUP OF COMPANIES Index to Unaudited Interim Condensed Combined Financial Statements Page(s) UNAUDITED INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS Unaudited Interim Condensed Combined Statements of Financial Position .............................................. 3 Unaudited Interim Condensed Combined Statements of Operations ......................................................... 4 Unaudited Interim Condensed Combined Statements of Changes in Members’ Equity ............................. 5 Unaudited Interim Condensed Combined Statements of Cash Flows ........................................................ 6 Notes to Unaudited Interim Condensed Combined Financial Statements ................................................. 7 (2) HARVEST ENTERPRISES GROUP OF COMPANIES Unaudited Interim Condensed Combined Statements of Operations For the Three and Nine Month Periods Ended September 30, 2018 and 2017 (Expressed in United States Dollars) Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Revenue $ 11,153,726 $ 6,881,604 $ 30,012,392 $ 15,615,722 Cost of Goods Sold (5,565,725) (3,420,651) (12,642,080) (6,774,484) Gross Profit Before Biological Asset Adjustments 5,588,001 3,460,953 17,370,312 8,841,238 Unrealized Gain on Changes in Fair Value of Biological Asset 5,690,989 885,082
    [Show full text]
  • Before the Ohio Senate Government Oversight and Reform Committee - Interested Party Testimony Regarding House Bill No
    Before The Ohio Senate Government Oversight and Reform Committee - Interested Party Testimony Regarding House Bill No. 523 In View Of Other State Regulatory Approaches To Medicinal Cannabis by Ted Bibart, Legislative Analyst Benesch, Friedlander, Coplan, & Aronoff LLP Introduction and Objectives • As a Legislative Analyst I am tasked with analyzing complex statutory and regulatory schemes to determine application, compliance, and public policy significance. • I am not yet licensed to practice law in the state of Ohio, and sit for the Ohio bar examination this July. • Benesch is not actively lobbying for anyone on the issue of medicinal cannabis in Ohio. • Instead, I offer “interested party” testimony regarding the House Bill No. 523 (HB 523) and comparative state statutory and regulatory approaches to the implementation of legalized medicinal cannabis. 2 Evaluation Criteria • Federal Harmony – The given state’s statutes and regulations are viewed in the light of federal prohibition and the corresponding tension presented by Department of Justice (“DOJ”) guidance, and historic trends. • Patient Access – The state’s statutory and regulatory scheme is then evaluated for its functional distribution of medicinal cannabis to patients in need. • Viability – The statutes and regulations are then appraised for their effective creation, implementation, and regulation of the long-term market infrastructure necessary to produce and sustain a workable program. 3 Federal Harmony • The relevant historical trend is evident in the trilogy of guidance issued by the DOJ, starting with the memorandum authored by Deputy Attorney General David W. Ogden on October 19, 2009 (the “Ogden Memo”). – Here, the Ogden Memo provides clarification and guidance to federal prosecutors in States that have some form of legalized cannabis use advising against enforcement of federal prohibition as an inefficient use of limited federal resources.
    [Show full text]
  • Green Harvest Health, a Medical Cannabis Clinic Located in Pickerington, OH
    Biography Certified physician development coach, Ohio, Career coaching, Life coaching, Communication coaching, Midwest Dr. Bridget Williams is the owner of Green Harvest Health, a medical cannabis clinic located in Pickerington, OH. Green Harvest Health is the only medical cannabis clinic in Ohio with life and wellness coaching incorporated into the practice. Dr. Williams brings nearly 20 years of experience in family and occupational medicine from Cleveland Clinic and training in life and cannabis coaching to her practice. Her practice provides comprehensive and affordable care for the metropolitan Columbus area as well as satellite offices in Cleveland and Cincinnati. GreenHarvest.Health About Bridget Williams, MD My clients are physicians and other professionals struggling with stress, identity and the difficulties of being “the only” in workplace situations. They are seeking a better work/life balance and desire to soar with greater personal and professional confidence. It is through self-discovery that habits can be broken, and significant changes can be made. Client and Business Focus My clients are typically physicians and other professionals who feel they could do better at their jobs and their personal lives but tend to be struggling to find clarity regarding what is missing. They describe themselves as “the only” in their workplace or educational environment. Whether they are the only woman, minority, LBGTQ or simply different in thought. They struggle in believing they are good enough and that they earned their credentials on their own intelligence and hard work. My clients realize that the strong confident person they once were is shrinking and becoming less identifiable. I work with these amazing people to help them build awareness of themselves and their environment.
    [Show full text]
  • Should the United States Legalize Cannabis?
    Should the United States Legalize Cannabis? An Interactive Qualifying Project submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE in partial fulfilment of the requirements for the degree of Bachelor of Science by David Quinn Zachary Belohoubek Date: 4 May 2016 Approved By: Professor Patricia Stapleton Worcester Polytechnic Institute This report represents work of WPI undergraduate students submitted to the faculty as evidence of a degree requirement. WPI routinely publishes these reports on its web site without editorial or peer review. For more information about the projects program at WPI, see http://www.wpi.edu/Academics/Projects. 1 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................................... 2 TABLE OF TABLES ..................................................................................................................... 3 TABLE OF FIGURES .................................................................................................................... 3 ABSTRACT ................................................................................................................................... 4 INTRODUCTION ........................................................................................................................ 10 BACKGROUND .......................................................................................................................... 13 EARLY HISTORY OF CANNABIS IN AMERICA .............................................................
    [Show full text]
  • Before the Ohio House of Representatives Select Committee on Medical Marijuana - Interested Party Testimony Regarding House Bill No
    Before The Ohio House Of Representatives Select Committee on Medical Marijuana - Interested Party Testimony Regarding House Bill No. 523 In View Of Other State Regulatory Approaches To Medicinal Cannabis by Ted Bibart, Legislative Analyst Benesch, Friedlander, Coplan, & Aronoff LLP Introduction and Objectives • As a Legislative Analyst I am tasked with analyzing complex statutory and regulatory schemes to determine application, compliance, and public policy significance. • I am not yet licensed to practice law in the state of Ohio, and sit for the Ohio bar examination this July. • Benesch is not actively lobbying for anyone on the issue of medicinal cannabis in Ohio. • Instead, I offer “interested party” testimony regarding the proposed House Bill No. 523 (HB 523) and comparative state statutory and regulatory approaches to the implementation of legalized medicinal cannabis. 2 Evaluation Criteria • Federal Harmony – The given state’s statutes and regulations are viewed in the light of federal prohibition and the corresponding tension presented by Department of Justice (“DOJ”) guidance, and historic trends. • Patient Access – The state’s statutory and regulatory scheme is then evaluated for its functional distribution of medicinal cannabis to patients in need. • Viability – The statutes and regulations are then appraised for their effective creation, implementation, and regulation of the long-term market infrastructure necessary to produce and sustain a workable program. 3 Federal Harmony • The relevant historical trend is evident in the trilogy of guidance issued by the DOJ, starting with the memorandum authored by Deputy Attorney General David W. Ogden on October 19, 2009 (the “Ogden Memo”). – Here, the Ogden Memo provides clarification and guidance to federal prosecutors in States that have some form of legalized cannabis use advising against enforcement of federal prohibition as an inefficient use of limited federal resources.
    [Show full text]
  • Daniel J. Mallinson , A. Lee Hannah , Brad C. Steel , Lana G. Jones
    Implementation of Medical Cannabis in Pennsylvania and Ohio Daniel J. Mallinson1, A. Lee Hannah2, Brad C. Steel2, Lana G. Jones2 1School of Public Affairs, Penn State Harrisburg and 2School of Public and International Affairs, Wright State University [email protected] Since 1996, 33 states and the District of Columbia have adopted medical cannabis programs. Not all programs, however, are the same. This is even the case in states like Pennsylvania and Ohio who adopted medical cannabis in the same year and share many other social, political, and demographic characteristics. The purpose of this research is to compare these two similar cases with dissimilar outcomes. Pennsylvania has moved more quickly to implement medical cannabis, though it is not clear yet which program will be more effective in the long-run. Using implementation theory, we examine how policy design and political environment shape the implementation of medical cannabis in the two states. Motivations Federal Inducements Marijuana is still a Schedule I drug under the Controlled Substances Act of 1970, meaning it • Identify measurable independent and dependent variables for medical cannabis has no recognized medicinal use. However, federal enforcement signals have varied over implementation time. Our previous research found no impact of federal enforcement signals on medical • Compare two cases with substantial political, social, and demographic similarities in order cannabis adoption [2]. to identify specific differences that caused differences in implementation outcomes • Develop a framework for a 33 state study State Actors Implementation Theory Legislatures We rely on the third generation of implementation theory [1] as our framework for understanding medical cannabis implementation.
    [Show full text]
  • Bowling Green Ohio Pot Penalties
    Bowling Green Ohio Pot Penalties Intercolumnar Traver usually clinging some Shaun or tear-gas sith. Gandhian and striped Cosmo deoxygenized his balmorals endues dulcify adumbratively. Defrayable and hammerless Englebert never forearm his unknightliness! Made against john geddert were apprehended less than ohio pot Penalties If smart contract meets all rural the requirements of that law the worker. 2421 Fitzgerald Industrial Dr Bowling Green KY 42101 270 43-6750. Individuals were indicted Matthew Edward Day age 20 of solar City Ohio. Ohio Gun and CCW Laws Links to scope key sections of Ohio law though are. Issued by recent Supreme manual of Ohio on all documents filed with the real An attorney. Find it best traffic tickets attorney serving Bowling Green background top Kentucky lawyers' fees client reviews lawyer rating case results education awards. From left Michael Che Walters 39 of Bowling Green Ohio and. What's better with wax pen or a vape pen? It did increase sentences for green who recklessly deal drugs within. How much pot plant a felony in Alabama? Bath salts Ecstasy heroin marijuana prescription opioids. Columbus City or last July reduced penalties for many up to 7. If object have been charged with drug possession our Bowling Green Ohio drug. Vacation House rentals in 4 Bedroom by owner 16767. OSBA's Weekly Legislative Report Ohio State Bar Association. Crime rate in those city highlighted that Paducah Mayfield Oak Grove Bowling Green. DUI Attorney Bowling Green OH Bowiling Green Ohio Lawyer. Maryland Master Gardener Handbook should List are Core Competencies Resume Examples Daniweb Bowling Green Ohio Pot Penalties Details Baldor Grinder.
    [Show full text]
  • (Formerly Securecom Mobile Inc.) Management's Discussion & Analysis Company Overview
    LIBERTY HEALTH SCIENCES INC. (FORMERLY SECURECOM MOBILE INC.) MANAGEMENT’S DISCUSSION & ANALYSIS This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Liberty Health Sciences Inc., (the “Company” or “Liberty”) (formerly SecureCom Mobile Inc.), is for the three months ended May 31, 2019. It is supplemental to, and should be read in conjunction with the Company’s unaudited interim condensed consolidated financial statements and the accompanying notes for the three month period ended May 31, 2019 (the “Q1 2020 Financials”), as well as the audited consolidated financial statements for the year ended February 28, 2019. The Company’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). This MD&A has been prepared by reference to the MD&A disclosure requirements established under National Instrument 51-102 “Continuous Disclosure Obligations” (“NI 51-102”) of the Canadian Securities Administrators. Additional information regarding Liberty Health Sciences Inc. is available on our website at www.libertyhealthsciences.com or through the SEDAR website at www.sedar.com. In this MD&A, reference is made to gross profit before biological asset adjustments, gross margin before biological asset adjustments and adjusted earnings before interest, tax, depreciation and amortization (“EBITDA”), which are not measures of financial performance under IFRS and may not be comparable to similarly titled measures used by other companies. The Company calculates each as follows: • Gross profit before biological asset adjustments is equal to gross profit less the non-cash change in the fair value on harvest and less the non-cash change in the fair value on cost of goods sold, if any.
    [Show full text]
  • Ohio Patient Network
    Ohio Ohio Patient Network - The Ohio Patient Network is a 501(c)(3) non-profit coalition of patients, caregivers, activists and medical professionals who support the compassionate use of cannabis for various medicinal purposes. Our mission is to coordinate information between patients, medical professionals, and attorneys, as well as to educate the public and keep the interested current with the movement`s news. Ohio Patient Network (OPN), P.O. Box 26353. Columbus, OH 43226. email - [email protected] , or Visit - http://www.ohiopatient.net The Ohio Patient Action Network is a sister to the charitable Ohio Patient Network for the purpose of lobbying, at all levels of government, for the therapeutic use of cannabis, as well as for or against existing or proposed legislation that involves therapeutic cannabis, and to engage in any other lawful purpose which the directors may approve. Visit - http://www.ohiopatientaction.org/ OPN Store - Support Medical Cannabis In Ohio! * Ohio Patient Network is a non-profit coalition of patients, caregivers, activists and medical professionals who support the compassionate use of cannabis for ... Visit - http://www.cafepress.com/OPNstore MMJ Action Network | Your Complete Guide To Medical Marijuana, Everything You Have Always ... Ohio Revised Code or be held liable for the patient's medical use of cannabis. ... visit - http://www.mmjactionnetwork.com/index.html ASA : OHIO | Medical cannabis (medical marijuana) resources in Ohio ... Find info here on the therapeutic uses of and research on medical cannabis. ... visit - http://www.safeaccessnow.org/article.php?id=260 Medical Cannabis Bill to Be Introduced in Ohio Senate | Proposal to Legalize Medical Marijuana in State Senate.
    [Show full text]
  • Liberty Q2 2019
    LIBERTY HEALTH SCIENCES INC. (FORMERLY SECURECOM MOBILE INC.) MANAGEMENT’S DISCUSSION & ANALYSIS This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Liberty Health Sciences Inc., (the “Company” or “Liberty”) (formerly SecureCom Mobile Inc.), is for the three and six month period ended August 31, 2018. It is supplemental to, and should be read in conjunction with the Company’s unaudited interim condensed consolidated financial statements and the accompanying notes for the three and six month period ended August 31, 2018 (the “Q2 Financials”), as well as the audited consolidated financial statements for the period from May 1, 2017 to February 28, 2018. The Company’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). This MD&A has been prepared by reference to the MD&A disclosure requirements established under National Instrument 51-102 “Continuous Disclosure Obligations” (“NI 51-102”) of the Canadian Securities Administrators. Additional information regarding Liberty Health Sciences Inc. is available on our website at www.libertyhealthsciences.com or through the SEDAR website at www.sedar.com. In this MD&A, reference is made to adjusted gross profit, adjusted gross margin and adjusted earnings before interest, tax, depreciation and amortization (“EBITDA”), which are not measures of financial performance under IFRS and may not be comparable to similarly titled measures used by other companies. The Company calculates each as follows: • Adjusted gross profit is equal to gross profit less the non-cash increase in the fair value on harvest, less the non-cash increase in the fair value on cost of goods sold, less certain costs of goods sold and less non-cash depreciation, if any.
    [Show full text]
  • The Hazy Rollout of Ohio's Medical Marijuana Control Program (MMCP
    MY BENESCH MY TEAM Health Care & Life Sciences CLIENT BULLETIN October 2016 The Hazy Rollout of Ohio’s Medical Marijuana Control Program (MMCP) By Jeff McCourt and Dan O’Brien The ultimate functionality of the MMCP several of the largest law firms in the state – both in terms of the opportunity for were forced to suspend their activities in seriously ill patients to access medicine, the space while the Supreme Court rushed and the opportunity for market participants through an amendment to the ethics rules. to create a sustainable program to serve Such an amendment was adopted on those patients – will be determined by the September 20th, allowing doctors, patients extensive rulemaking and licensure process and cannabis businesses to obtain legal to be carried out by the Department of representation in Ohio. Jeff McCourt Dan O’Brien Commerce, the state Pharmacy Board, and Adding further confusion to the mix, the the state Medical Board over the next two When Ohio House Bill 523 (HB 523) became Ohio Municipal League has launched years. Several early indicators, however, effective on September 8, 2016, Ohio joined a statewide effort to educate local have begun to cast doubt on the program’s the company of 25 other states, the District governments about HB 523. Given the lack viability as written. This article recaps of Columbia, and several U.S. territories of clarity on how the state regulations will several recent developments in the MMCP that have legalized cannabis for medicinal operate and where cannabis operations will and addresses specifically the Medical purposes. Modeled after highly restrictive be located throughout the state, dozens Board’s recent guidance on the “affirmative regimes adopted by state legislatures of local governments have chosen to defense” provision of HB 523, the only part in Illinois, Maryland, and New York, the preemptively adopt bans or moratoriums on of the law that is currently operational.
    [Show full text]